Back to search results

Long-Term Outcomes of Teplizumab in Routine Clinical Care

Israel
Recruiting

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Type 1 Diabetes

Locations
  • Investigational Site Number: 3760001, Ramat Gan, Israel
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)